West Pharmaceutical Services Inc. (WST) Just Recorded A Sigfniciant Increase

September 17, 2017 - By Marry Poplack

Investors sentiment decreased to 0.96 in Q4 2016. Its down 0.05, from 1.01 in 2016Q3. It dropped, as 31 investors sold West Pharmaceutical Services Inc. shares while 97 reduced holdings. 45 funds opened positions while 78 raised stakes. 66.40 million shares or 1.35% more from 65.52 million shares in 2016Q3 were reported.
Amalgamated Bancorporation has 0.05% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 13,879 shares. Bamco Ny invested in 1.02% or 2.14 million shares. Thompson Rubinstein Inv Mngmt Or invested in 4,000 shares. Commercial Bank Of Montreal Can owns 3,454 shares for 0% of their portfolio. Aperio Llc invested in 0.02% or 28,719 shares. M&T National Bank & Trust invested in 64,658 shares. Blackrock Advsrs Ltd has 43,297 shares for 0% of their portfolio. 480,136 were accumulated by Jennison Associate Llc. Regions invested in 0% or 4,168 shares. Sterling Cap Management Limited Liability has 0.3% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 397,954 shares. Great West Life Assurance Can reported 41,391 shares. Comerica Bankshares has invested 0.04% in West Pharmaceutical Services Inc. (NYSE:WST). Moreover, Amg Natl Savings Bank has 0.03% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 3,594 shares. Moreover, Wheatland Inc has 0.42% invested in West Pharmaceutical Services Inc. (NYSE:WST). Neuberger Berman Gru Ltd Liability Co holds 3.99M shares or 0.45% of its portfolio.

Since May 2, 2017, it had 0 insider purchases, and 2 insider sales for $5.63 million activity. Malone Daniel had sold 4,124 shares worth $384,816 on Tuesday, May 2. Another trade for 54,996 shares valued at $5.25M was sold by FEDERICI WILLIAM J.

The stock of West Pharmaceutical Services Inc. (NYSE:WST) is a huge mover today! The stock increased 4.59% or $4.21 on September 15, reaching $95.91. About 761,446 shares traded or 112.33% up from the average. West Pharmaceutical Services Inc. (NYSE:WST) has risen 33.75% since September 17, 2016 and is uptrending. It has outperformed by 17.05% the S&P500.
The move comes after 8 months positive chart setup for the $7.10B company. It was reported on Sep, 17 by Barchart.com. We have $102.62 PT which if reached, will make NYSE:WST worth $497.00M more.

Analysts expect West Pharmaceutical Services Inc. (NYSE:WST) to report $0.53 EPS on October, 26.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $0.53 EPS. WST’s profit would be $39.23M giving it 45.24 P/E if the $0.53 EPS is correct. After having $0.51 EPS previously, West Pharmaceutical Services Inc.’s analysts see 3.92 % EPS growth.

West Pharmaceutical Services Inc. (NYSE:WST) Ratings Coverage

Among 3 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. West Pharmaceutical Services had 10 analyst reports since August 4, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Hold” rating in Thursday, July 27 report. The company was maintained on Thursday, June 29 by Jefferies. Jefferies maintained the stock with “Hold” rating in Monday, September 11 report. As per Friday, October 28, the company rating was upgraded by Wells Fargo. On Friday, January 8 the stock rating was initiated by Janney Capital with “Buy”. The company was downgraded on Tuesday, August 4 by Zacks. The firm earned “Buy” rating on Friday, September 15 by Jefferies. Wells Fargo downgraded the stock to “Market Perform” rating in Wednesday, September 21 report. The stock of West Pharmaceutical Services Inc. (NYSE:WST) has “Outperform” rating given on Tuesday, March 22 by Wells Fargo. On Tuesday, June 6 the stock rating was maintained by Jefferies with “Hold”.

More news for West Pharmaceutical Services Inc. (NYSE:WST) were recently published by: Nasdaq.com, which released: “West Pharmaceutical Services (WST) Shares Cross Above 200 DMA” on September 01, 2017. Prnewswire.com‘s article titled: “West Announces Fall Investor Conference Schedule” and published on August 25, 2017 is yet another important article.

West Pharmaceutical Services, Inc. is a maker of packaging components and delivery systems for injectable drugs and healthcare products. The company has market cap of $7.10 billion. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. It has a 40.96 P/E ratio. The Company’s divisions include Proprietary Products and Contract-Manufactured Products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.